doi: 10.1038/ni.2853.
Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem
Affiliations
- PMID: 24747701
- PMCID: PMC4814932
- DOI: 10.1038/ni.2853
Item in Clipboard
Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem
Nat Immunol.
2014 May.
Abstract
Live and live-attenuated whole organism vaccines against Plasmodium falciparum malaria and cutaneous leishmaniasis due to Leishmania major remain the most uniformly effective vaccines against human parasitic diseases. These vaccines are discussed in terms of the nature of the T cell populations that mediate the strong and durable localized immunity to these infections, and the requirement for persisting antigen to generate and maintain the protective response. The difficulties in developing subunit vaccines that fulfill this requirement argue that despite their own formidable problems in manufacture and delivery, live and live- attenuated whole organism vaccines against human parasitic diseases should be vigorously pursued.
Similar articles
-
The Delay in the Licensing of Protozoal Vaccines: A Comparative History.Front Immunol. 2020 Mar 6;11:204. doi: 10.3389/fimmu.2020.00204. eCollection 2020. Front Immunol. 2020. PMID: 32210953 Free PMC article. Review.
-
Experimental models in vaccine research: malaria and leishmaniasis.Braz J Med Biol Res. 2013 Feb;46(2):109-16. doi: 10.1590/1414-431x20122460. Epub 2013 Feb 1. Braz J Med Biol Res. 2013. PMID: 23369975 Free PMC article. Review.
-
[The immunological aspects of tropical malaria related to the development of an antimalarial vaccine].Med Parazitol (Mosk). 2000 Apr-Jun;(2):56-8. Med Parazitol (Mosk). 2000. PMID: 10900926 Review. Russian. No abstract available.
-
Vaccines against the blood stages of falciparum malaria.Adv Exp Med Biol. 1998;452:193-205. doi: 10.1007/978-1-4615-5355-7_22. Adv Exp Med Biol. 1998. PMID: 9889974 Review. No abstract available.
-
An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum.Res Immunol. 1994 Jul-Aug;145(6):461-8. doi: 10.1016/s0923-2494(94)80177-0. Res Immunol. 1994. PMID: 7534937 Review. No abstract available.
Cited by
-
Naïve CD8 T cell IFNγ responses to a vacuolar antigen are regulated by an inflammasome-independent NLRP3 pathway and Toxoplasma gondii ROP5.PLoS Pathog. 2020 Aug 27;16(8):e1008327. doi: 10.1371/journal.ppat.1008327. eCollection 2020 Aug. PLoS Pathog. 2020. PMID: 32853276 Free PMC article.
-
Comparative analyses of parasites with a comprehensive database of genome-scale metabolic models.PLoS Comput Biol. 2022 Feb 23;18(2):e1009870. doi: 10.1371/journal.pcbi.1009870. eCollection 2022 Feb. PLoS Comput Biol. 2022. PMID: 35196325 Free PMC article.
-
Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development.Front Immunol. 2018 Feb 26;9:263. doi: 10.3389/fimmu.2018.00263. eCollection 2018. Front Immunol. 2018. PMID: 29535708 Free PMC article.
-
Healed Lesions of Human Cutaneous Leishmaniasis Caused By Leishmania major Do Not Shelter Persistent Residual Parasites.Front Cell Infect Microbiol. 2022 Jul 27;12:839216. doi: 10.3389/fcimb.2022.839216. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35967864 Free PMC article.
-
Fungal diseases as neglected pathogens: A wake-up call to public health officials.PLoS Negl Trop Dis. 2020 Feb 20;14(2):e0007964. doi: 10.1371/journal.pntd.0007964. eCollection 2020 Feb. PLoS Negl Trop Dis. 2020. PMID: 32078635 Free PMC article. No abstract available.
References
-
- Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME. 2013;162(3):144–155. - PubMed
-
- Hotez PJ, Ferris MT. Vaccine. 2006;24(31–32):5787–5799. - PubMed
-
- Sacks DL, Sher A, Riley EM, Wynn TA. In: Fundamental Immunology. sixth. Paul WE, editor. Lippincott, Williams & Wilkins; Philadelphia: 2008.
-
- Clyde DF, Most H, McCarthy VC, Vanderberg JP. The American journal of the medical sciences. 1973;266(3):169–177. - PubMed
-
- Nussenzweig RS, Vanderberg J, Most H, Orton C. Nature. 1967;216(5111):160–162. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
